A large cohort study of Danish children has found that the lightest and heaviest infants are at elevated risk of later developing hidradenit

". . . both dermcidin and the cytokine regulator interleukin (IL)‐37 were both significantly downregulated in the HS specimens. “These

The Organizing Committee of the 4th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) has issued a call for abstracts to be inclu

This year Hidradenitis Suppurativa Awareness Week runs from June 4 through 10. To mark the event, on Tuesday, June 5th at 7 p.m. EST, Ottawa

The Chronicle of Skin & Allergy For more information about the Skin Spectrum Summit series in Toronto (April 14, 2018), Montreal (May 12, 2018), and Vancouver (June 2, 2018), or to register now, visit www.skinspectrum.ca. #SkinSpectrumSummit #Ethnodermatology #Dermatology #SkinofColour #SkinofColor #Ethnicskin #AndrewAlexis #Darklypigmentedskin #psoriasis #Hidradenitissuppurativa #AfsanehAlavi #Melasma #HeatherWolleryLloyd #Toronto #SkinCancer #DavindraSingh #Sunprotection

T-helper 17 (Th17) immune cells appear to play a key role in the inflammation associated with hidrandenitis suppurativa (HS), suggesting the Th17 pathway may be a therapeutic target for treatment of the skin condition. The research was performed by a team of researchers from Trinity College Dublin, St. Vincent’s University Hospital, Elm Park, Ireland, and Tallaght Hospital, Tallaght, Ireland. Cells isolated from skin and blood samples obtained from HS patients and healthy vol

Therapies for hidradenitis suppurativa (HS)/acne inversa should be based upon evaluation of the inflammatory components, as well as the scarring, and should be directed by an evidence-based approach, according to a study published in the journal Reviews in Endocrine and Metabolic Disorder (September 2016; 17(3):343–351). “We wanted an evidence-based approach because the treatment of HS—until the publication of the European [Dermatology Forum] guidelines—had been based somewha

Registration is still open for SHSA 2016, the Symposium on Hidradenitis Suppurativa Advances. This, the first North American scientific symposium on hidradenitis suppurativa (HS), is being held in Toronto this coming weekend, Oct. 22 and 23. Held at Women’s College Hospital, the symposium’s goal is to bring together leading academic scientists, clinicians and researchers to share their experiences with the skin condition and to discuss the latest HS-related innovations and re